Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673865 | SCV000799116 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-04-12 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075394 | SCV001241016 | pathogenic | Retinal dystrophy | 2018-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861824 | SCV002240288 | pathogenic | not provided | 2023-09-14 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 3546 of the USH2A protein (p.Gly3546Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Usher syndrome (PMID: 22004887, 22009552, 24944099). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 557692). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on USH2A protein function. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003453368 | SCV004182197 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453367 | SCV004182198 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453368 | SCV004206383 | likely pathogenic | Retinitis pigmentosa 39 | 2022-10-11 | criteria provided, single submitter | clinical testing |